Fed. Circ. Won't Review Ruling Nixing Cordis Stent Patents
The full Federal Circuit on Friday declined to review a ruling that two Cordis Corp. and Wyeth Pharmaceuticals Inc. patents covering a drug used in stents are invalid, turning aside the...To view the full article, register now.
Already a subscriber? Click here to view full article